Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free MGX Stock Alerts

Metagenomi (MGX) Stock Forecast & Price Target

Metagenomi logo
$1.43 +0.02 (+1.42%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$1.44 +0.01 (+0.91%)
As of 04:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Metagenomi - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy
Based on 5 Analyst Ratings
Sell
1
Hold
0
Buy
4

Based on 5 Wall Street analysts who have issued ratings for Metagenomi in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 5 analysts, 1 has given a sell rating, 3 have given a buy rating, and 1 has given a strong buy rating for MGX.

Consensus Price Target

$10.00
599.30% Upside
According to the 5 analysts' twelve-month price targets for Metagenomi, the average price target is $10.00. The highest price target for MGX is $12.00, while the lowest price target for MGX is $7.00. The average price target represents a forecasted upside of 599.30% from the current price of $1.43.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MGX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Metagenomi and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MGX Analyst Ratings Over Time

TypeCurrent Forecast
5/7/25 to 5/7/26		1 Month Ago
4/7/25 to 4/7/26		3 Months Ago
2/6/25 to 2/6/26		1 Year Ago
5/7/24 to 5/7/25
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$10.00$10.00$10.00$14.75
Forecasted Upside599.30% Upside635.29% Upside549.35% Upside920.76% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyBuy

MGX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MGX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Metagenomi Stock vs. The Competition

TypeMetagenomiMedical CompaniesS&P 500
Consensus Rating Score
2.80
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside599.30% Upside913.16% Upside14.02% Upside
News Sentiment Rating
Neutral News

See Recent MGX News
Positive News
Positive News
Export
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
5/1/2026
Weiss Ratings logo
Weiss Ratings
Not Rated
 UpgradeSell (E+) ➝ Sell (D-)
10/17/2025
Zacks Research logo
Zacks Research
Not Rated
 UpgradeHold ➝ Strong-Buy
8/19/2025
HC Wainwright logo
HC Wainwright
3 of 5 stars
Mitchell S.
Mitchell S.
Not Rated
Reiterated RatingBuy$7.00+264.58%
8/15/2025
Chardan Capital logo
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Geulah Livshits
Geulah Livshits
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetBuy$12.00 ➝ $11.00+491.40%
8/14/2025
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Yanan Zhu
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetOverweight$16.00 ➝ $12.00+531.58%
8/15/2024
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetOutperform$22.00 ➝ $17.00+451.95%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:34 AM ET.


MGX Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Metagenomi is $10.00, with a high forecast of $12.00 and a low forecast of $7.00.

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Metagenomi in the last year. There is currently 1 sell rating, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MGX shares.

According to analysts, Metagenomi's stock has a predicted upside of 599.30% based on their 12-month stock forecasts.

Over the previous 90 days, Metagenomi's stock had 1 upgrade by analysts.

Metagenomi has been rated by research analysts at Weiss Ratings in the past 90 days.

Analysts like Metagenomi more than other "medical" companies. The consensus rating for Metagenomi is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how MGX compares to other companies.

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Metagenomi Recommendations


This page (NASDAQ:MGX) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel